(Inclusive of all taxes)
Zubidox 50 mg Injection is used in combination with other medicines to treat certain types of bladder, breast, lung, stomach, and ovarian cancer, Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that originates in the cells of the immune system), and certain types of leukaemia (cancer of the white blood cells), including acute lymphocytic leukaemia (ALL) and acute myeloid leukaemia (AML). Zubidox Injection is also used alone and in combination with other drugs to treat certain types of thyroid cancer and certain types of soft tissue or bone sarcoma (cancer that forms in muscles and bones). It is also used to treat neuroblastoma (cancer that starts in nerve cells and occurs mainly in children) and Wilms tumour (a type of kidney cancer that occurs in children). Zubidox 50 mg belongs to a class of drugs called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.
Zubidox 50 should not be used in patients with severe liver disease, severe heart problems, very low blood cell counts caused by prior chemotherapy, or if you recently had a heart attack.
Breast cancer: Zubidox 50 mg Injection is used to treat Breast cancer is a type of cancer that affects the cells in the breast tissue. It is the second most common type of cancer in women and is often characterized by the presence of a tumour or lump in the breast.
Bladder cancer: Zubidox Injection is used in the treatment of Bladder cancer is a type of cancer that affects the bladder, which is a muscular organ in the lower abdomen that stores urine. It is most common in men over the age of 50 and is usually found in the cells lining the inside of the bladder.
Kaposi's sarcoma: Zubidox 50 mg is used in the treatment of Kaposi's sarcoma is a type of cancer that can affect the skin, mouth, and internal organs. It is caused by a virus called human herpesvirus 8 (HHV-8), which is also known as Kaposi's sarcoma-associated herpesvirus (KSHV). Kaposi's sarcoma is more common in people with compromised immune systems, such as people with HIV/AIDS or organ transplant recipients taking immunosuppressive drugs.
Hodgkin's lymphoma: Zubidox 50 is used in the treatment of Hodgkin's lymphoma, also known as Hodgkin's disease, which is a type of cancer that affects the lymphatic system.
Acute lymphocytic leukaemia(ALL): Zubidox 50 mg Injection is used in the treatment of Acute lymphocytic leukaemia a type of cancer that affects the blood and bone marrow.
Zubidox is a chemotherapy medication that is used to treat a variety of cancers. It works by interfering with the DNA of cancer cells, which can slow their growth and division. Some potential benefits of Zubidox Injection treatment include:
Zubidox 50 may show to be effective in treating a variety of cancers and is often used in combination with other chemotherapy medications.
Zubidox 50 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Zubidox Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Zubidox 50 will depend on the clinical condition of the patient's age and medical history, and other factors. It is important to follow your doctor's instructions carefully when using this medication. Do not self-administered.
Zubidox interacts with DNA by inhibition and the intercalation of the macromolecular biosynthesis. Zubidox 50 mg Injectionstabilizes the topoisomerase II complex after it breaks the chain of the DNA needed for replication. Zubidox Injection prevents the double helix DNA to get sealed and it gradually stops the replication process. Zubidox 50 may also increase quinone-type free radical production, hence contributing to its cytotoxicity.
It is not recommended to breastfeed while taking Zubidox. Zubidox Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Zubidox 50, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Zubidox 50 should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Zubidox 50 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Zubidox may need to be adjusted in patients with liver disease.
Use of Zubidox 50 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Zubidox 50 mg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
Zubidox 50 mg Injection is safe to use in patients with kidney disease. No dose adjustment of Zubidox 50 mg Injection is recommended. If you experience any side effects please consult your doctor.
Zubidox Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Zubidox.
It is generally not recommended to drink alcohol while taking Zubidox 50 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
1. Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, Usp To Its Portfolio Of Off-patent Oncology Products, Pfizer Inc, Available Form
2. Adriamycin (doxorubicin Hcl) For Injection, Usp, Manufactured, Bedford Laboratories, Product Monograph
3. Doxorubicin, Cancer Research Uk, Available Form